---
document_datetime: 2023-11-15 10:07:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/feraccru-epar-all-authorised-presentations_en.pdf
document_name: feraccru-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9451363
conversion_datetime: 2025-12-20 07:29:34.578982
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU (MA) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size           |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------|
| EU/1/15/1075/001 | Feraccru          | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 56 capsules         |
| EU/1/15/1075/002 | Feraccru          | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 50 capsules         |
| EU/1/15/1075/003 | Feraccru          | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 14 capsules         |
| EU/1/15/1075/004 | Feraccru          | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 100 (2x50) capsules |